Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Bruce Walcheck

10PUBLICATIONS

28CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityHaematological tumoursMedical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jul 25, 2024

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells.

Anders W Matson, Rob Hullsiek, Kate J Dixon

|Dec 06, 2023

iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.

Kristin M Snyder, Kate J Dixon, Zachary Davis

|Jul 25, 2023

Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization.

Judith Cruz Amaya, Bruce Walcheck, Julie Smith-Gagen

|Mar 07, 2023

Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production.

James D Dahlvang, Jenna K Dick, Jules A Sangala

|Aug 02, 2022

Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia.

Frank Cichocki, Jodie P Goodridge, Ryan Bjordahl

|Nov 13, 2021

Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor.

Elisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris

Pageof 2

Frequent Collaborators

2 joint publications

Martin Felices

1 joint publications

Hallie M Hintz

1 joint publications

Kristin M Snyder

1 joint publications

Elisa C Toffoli

1 joint publications

Abdolkarim Sheikhi

1 joint publications

Amanda van Vliet

1 joint publications

Henk M W Verheul

1 joint publications

Jurriaan Tuynman

1 joint publications

Frank Cichocki

1 joint publications

Jodie P Goodridge

Frequent Collaborators

2 joint publications

Martin Felices

1 joint publications

Hallie M Hintz

1 joint publications

Kristin M Snyder

1 joint publications

Elisa C Toffoli

Top Related Videos

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Published on : Dec 29, 2012

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

See more related videos

Top Related Videos

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Published on : Dec 29, 2012

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

See more related videos